Seres Therapeutics Stock Forecast

Big movements in Seres Therapeutics stock price on Monday moving 18.52% between high and low
(Updated on May 06, 2024)

MCRB Signals & Forecast

Mostly positive signals in the chart today. The Seres Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.04 and $0.784. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 112.54%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Seres Therapeutics stock

Seres Therapeutics finds support from accumulated volume at $1.14 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.200 between high and low, or 18.52%. For the last week, the stock has had daily average volatility of 14.59%.

The Seres Therapeutics stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs. Since the Seres Therapeutics has been rising for 8 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stop-loss: $1.15 (-3.28%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 86 and this increases the risk substantially. There is a buy signal from a pivot bottom found 11 days ago.)

Trading Expectations (MCRB) For The Upcoming Trading Day Of Tuesday 7th

For the upcoming trading day on Tuesday, 7th we expect Seres Therapeutics to open at $1.18, and during the day (based on 14 day Average True Range), to move between $1.09 and $1.29, which gives a possible trading interval of +/-$0.0983 (+/-8.26%) up or down from last closing price. If Seres Therapeutics takes out the full calculated possible swing range there will be an estimated 16.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.23 (3.36%) than the support at $1.14 (4.20%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Seres Therapeutics stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 3.625 Buy Candidate Unchanged

Predicted Opening Price for Seres Therapeutics of Tuesday, May 7, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.